Vancomycin bonded to bone grafts prevents bacterial colonization

Area of Science:

• Biomaterials Science
• Infectious Diseases
• Orthopedic Surgery

Background:

• Bone allografts are susceptible to bacterial colonization, leading to infections.
• Vancomycin (VAN) modification of allografts is a strategy to prevent such infections.
• Understanding the efficacy and stability of VAN-modified allografts is crucial.

Purpose of the Study:

• To evaluate the ability of vancomycin-modified bone allografts to resist bacterial colonization and biofilm formation.
• To assess the stability and toxicity of covalently attached vancomycin on allografts.
• To determine the effectiveness of VAN-modified allografts against specific bacterial strains.

Main Methods:

• Bone allografts were modified by covalently bonding vancomycin.
• Modified allografts were challenged with Staphylococcus aureus and Escherichia coli.
• Colonization and biofilm formation were quantified.
• Stability of the attached vancomycin was assessed over 60 days.
• Osteoblast viability and colonization were measured.

Main Results:

• Covalently bonded VAN significantly decreased Staphylococcus aureus colonization (0.8–2.0 log(10) CFU).
• VAN-modified surfaces resisted biofilm formation, even in complex topographical areas.
• The attached VAN remained stable (75–100% of initial levels) for 60 days in aqueous media and air.
• VAN-modified allografts were ineffective against Gram-negative Escherichia coli.
• No adverse effects on osteoblast colonization or viability were observed.

Conclusions:

• Covalently tethered vancomycin on bone allografts is a stable and effective method for inhibiting Gram-positive bacterial colonization and biofilm formation.
• This approach shows promise in reducing bone graft-associated infections without compromising osteoblast health.
• Further research is warranted to address efficacy against Gram-negative bacteria.